We have collected information about Dendrimer Nanoparticles For Ocular Drug Delivery for you. Follow the links to find out details on Dendrimer Nanoparticles For Ocular Drug Delivery.
https://www.researchgate.net/publication/235627350_Dendrimer_Nanoparticles_for_Ocular_Drug_Delivery
Dendrimer Nanoparticles for Ocular Drug Delivery Article in Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics 29(2 ...
https://www.liebertpub.com/doi/10.1089/jop.2012.0232
Mar 13, 2013 · Dendrimer Nanoparticles for Ocular Drug Delivery. Siva P. Kambhampati, and ; ... It represents a great opportunity for nanomedicine, since it is readily accessible—allowing for direct drug/gene delivery to maximize the therapeutic effect and minimize side effects. The development of appropriate delivery systems that can sustain and deliver ...Author: Siva P. Kambhampati, Rangaramanujam M. Kannan
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693026/
Jun 18, 2013 · Ocular drug transport barriers pose a challenge for drug delivery comprising the ocular surface epithelium, the tear film and internal barriers of the blood-aqueous and blood-retina barriers. Ocular drug delivery efficiency depends on the barriers and the clearance from the choroidal, conjunctival vessels and lymphatic.Author: Hong-Yan Zhou, Ji-Long Hao, Shuang Wang, Yu Zheng, Wen-Song Zhang
https://jhu.pure.elsevier.com/en/publications/dendrimer-nanoparticles-for-ocular-drug-delivery-4
title = "Dendrimer nanoparticles for ocular drug delivery", abstract = "Eye is a unique organ of perfection and complexity, and is a microcosm of the body in many ways. It represents a great opportunity for nanomedicine, since it is readily accessible - allowing for direct drug/gene delivery to maximize the therapeutic effect and minimize side ...Author: Siva P. Kambhampati, Rangaramanujam M. Kannan
https://www.researchgate.net/publication/317140606_Dendrimers_for_Ocular_Drug_Delivery
Despite advances in ocular drug therapy research, the focus on pediatric ocular drug delivery continues to be highly underrepresented due to the limited number of degenerative ocular diseases with ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694674/
The ideal ocular drug delivery system should be nonirritating, isotonic, biocompatible, and biodegradable. It should also prolong the release of the drug, reduce side effects, and target the desirable eye segment. Investigations of targeted drug–dendrimers for their use in different ocular diseases are discussed ahead.Author: Marina Kalomiraki, Kyriaki Thermos, Nikos A Chaniotakis
https://pdfs.semanticscholar.org/1242/74eddf497a5b1d37d930a2c6b3c5dd53e886.pdf
Dendrimer Nanoparticles for Ocular Drug Delivery Siva P. Kambhampati1,2 and Rangaramanujam M. Kannan1 Abstract Eye is a unique organ of perfection and …
https://pubs.acs.org/doi/abs/10.1021/nn301873v
A degradable hydrogel formed by dendrimer-encapsulated platinum nanoparticles and oxidized dextran for repeated photothermal cancer therapy. Journal of Materials Chemistry B 2018, 6 ... Dendrimer Nanoparticles for Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics 2013, 29 (2) , 151-165. DOI: 10.1089/jop.2012.0232.Author: Hu Yang, Puneet Tyagi, Rajendra S. Kadam, Christopher A. Holden, Uday B. Kompella
https://www.sciencedirect.com/science/article/pii/S0079670013000853
Dendrimers in ocular delivery of bioactives. ... Route of drug delivery Dendrimer Limitations of conventional formulations Bioactive Advantages of dendritic formulation ... , nanoparticles , , , , and carbon nanotubes (CNTs) , , etc. The developed hybrid systems may have some path-breaking advantages in the field of drug delivery.Author: Prashant Kesharwani, Keerti Jain, Narendra Kumar Jain
https://www.sciencedirect.com/science/article/pii/S2211383516300855
3. Benefits and limitations of ocular delivery routes 3.1. Systemic administrations. Intravenous injection and oral dosing are known systemic administration methods for ocular drug delivery. Since the choroid of the eye has a vascular choroid plexus structure, drugs can easily enter the choroid through blood vessels.Author: Yuhua Weng, Juan Liu, Shubin Jin, Weisheng Guo, Xingjie Liang, Zhongbo Hu
Searching for Dendrimer Nanoparticles For Ocular Drug Delivery?
You can just click the links above. The data is collected for you.
